Products
Integrity / innovation / cooperation / sharing / win-win

Products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor developed ↔by Merck. In October 2006, Sitagliptin phosphate Januvia was app$roved by FDA as the first DPP4 inhibitor for the tr×eatment of type ⅱ diabetes mellitus. The characteristics of this¶ drug are that it can stimulate insulin secretion while reducing hun♦ger without causing weight gain. Hypoglycemia and edema will not occur, and it is suitab le for diabetic patients with poor blood glucose control and frequent hypoglycemia.

View details

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutic'al enterprise that is market-oriented and realizes in§dustrial development through R&D innovation and technology transformation.

View details

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the mos∑t important products for the treatment of arthritis. It is well tolerat→ed and has a low incidence of side effects

View details

Pranlukast

Pranlukast, developed by Ono, is one of the three ≈major leukotriene receptor antagonists. In clinical application, it has good therapeutic ≈effect on atopic asthma and other types of bronchial asthma, ♥and the market prospect is huge. In the major category of asthma druφgs, leukotriene receptor antagonists have the fastest grow≥ing market share.

View details

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterpr≈ise that is market-oriented and realizes industria↑l development through R&D innovation and technology transformation.

View details

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug approved by FDA  for Alzheimer's disease in the United States. Its treatment reaches the target dos₽e and has low toxic and side effects. It has been wid€ely recognized by our medical community, and good tolerance is its biggest adva↓ntage. In October 1999, Donepezil was launched in China under the trade name "Aricept&quΩot;, which is the main chemical drug against Alzheimer's disease. At preπsent, CFDA has approved a number of domestic enterprises to produce do✔nepezil preparations, the main dosage forms are tablets, capsu÷les, dispersive tablets, oral disintegrating table>ts.

View details

Almotriptan

Migraine medication for adolescents

View details

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (E®liquis, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor , was approved for use in the 27 EU member states. The world's first drug approved to pre∞vent venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replaλcement. From June 2019 to June 2020, the annual sales of aβpixaban products overseas reached about $15.4 billion, with a year-on-year growth of nearly 32%, anπd the API consumption reached about 23,960 kg, with a year-on-year growth of about 28%. ₹Compared with its main competitor, Rivaroxaban, the drug's annual ★overseas sales are about $4.5 billion higher.

View details

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical♦ enterprise that is market-oriented and realizes indust'rial development through R&D innovation and technology transformation.

View details
< 12 > proceed page